¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary action"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • buffer action
    ¿ÏÃæÀÛ¿ë
  • competitive action
    °æÀïÀÛ¿ë
  • compound muscle action potential
    º¹ÇÕ±Ù(À°)Ȱµ¿ÀüÀ§
  • compound nerve action potential
    º¹ÇսŰæÈ°µ¿ÀüÀ§
  • corrective action
    ±³Á¤Ã³Ä¡
  • curariform action
    Äí¶ó·¹À¯»çÀÛ¿ë
  • chronotropic action
    ½É¹Ú¼öº¯µ¿ÀÛ¿ë
  • dual block action
    ÀÌÁßÂ÷´ÜÀÛ¿ë
  • dynamic action
    µ¿·ÂÀÛ¿ë
  • diabetogenic action
    ´ç´¢º´À¯¹ßÀÛ¿ë
  • diuretic action
    ÀÌ´¢ÀÛ¿ë
  • gestagenic action
    ÇÁ·Î°Ô½ºÅ×·ÐÀÛ¿ë, Ȳüȣ¸£¸óÀÛ¿ë
  • immediate action
    Áï½ÃÀÛ¿ë
  • inhibitory action
    ¾ïÁ¦ÀÛ¿ë, ÀúÁöÀÛ¿ë
  • inotropic action
    ¼öÃàÃËÁøÀÛ¿ë
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • additive action
    ºÎ°¡ÀÛ¿ë
  • adverse action
    À¯ÇØÀÛ¿ë
  • antimicrobial action
    Ç×±ÕÀÛ¿ë
  • antipyretic action
    ÇØ¿­ÀÛ¿ë
  • bacteriocidal action
    »ì±ÕÀÛ¿ë
  • bacteriostatic action
    Á¤±ÕÀÛ¿ë
  • buffer action
    ¿ÏÃæÀÛ¿ë
  • diuretic action
    ÀÌ´¢ÀÛ¿ë
  • inhibitory action
    ¾ïÁ¦ÀÛ¿ë, ÀúÁöÀÛ¿ë
  • pharmacological action
    ¾à¸®ÀÛ¿ë
  • promotor action
    ÃËÁøÀÛ¿ë
  • action potential
    Ȱµ¿ÀüÀ§
  • action tremor
    Ȱµ¿¶³¸²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • chronotropic action
    ½É¹Ú¼öº¯µ¿ÀÛ¿ë
  • competitive action
    °æÀïÀÛ¿ë
  • corrective action
    ±³Á¤Ã³Ä¡
  • curariform action
    Äí¶ó·¹À¯»çÀÛ¿ë
  • diabetogenic action
    ´ç´¢º´À¯¹ßÀÛ¿ë
  • diastatic action
    ´çÈ­ÀÛ¿ë
  • dual block action
    ÀÌÁßÂ÷´ÜÀÛ¿ë
  • dynamic action
    µ¿·ÂÀÛ¿ë
  • gestagenic action
    ÇÁ·Î°Ô½ºÅ×·ÐÀÛ¿ë, Ȳüȣ¸£¸óÀÛ¿ë
  • immediate action
    Áï°¢ÀÛ¿ë
  • inhibitory action
    ¾ïÁ¦ÀÛ¿ë, ÀúÁöÀÛ¿ë
  • inotropic action
    ¼öÃàÃËÁøÀÛ¿ë
  • interferential action
    °£¼·ÀÛ¿ë
  • mass action
    Áú·®ÀÛ¿ë
  • neurotropic action
    Çâ½Å°æÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anabolic action
    (´Ü¹é)µ¿È­ÀÛ¿ë(Ó±ÛÜÔÒûùíÂéÄ)
  • analgesic action
    ÁøÅëÀÛ¿ë(òå÷ÔíÂéÄ).
  • anesthetic action
    ¸¶ÃëÀÛ¿ë(¡­íÂéÄ).
  • antidiuretic action
    Ç×ÀÌ´¢ÀÛ¿ë.
  • antifungal action
    Ç×Áø±ÕÀÛ¿ë
  • antimicrobial action
    Ç×±ÕÀÛ¿ë(¡­íÂéÄ).
  • antimuscarinic action
    Ç×¹«½ºÄ«¸°(¼º) ÀÛ¿ë(ù÷¡­(àõ) íÂéÄ).
  • antimuscarinic action
    Ç×¹«½ºÄ«¸°ÀÛ¿ë(ù÷¡­íÂéÄ).
  • antipyretic action
    ÇØ¿­ÀÛ¿ë(¡­íÂéÄ).
  • antispasmodic action
    Áø°æÀÛ¿ë(¡­íÂéÄ)
  • galvanic action
    °¥¹Ù´ÏÀÛ¿ë.
  • ganglionic blocking action
    ½Å°æÀýÂ÷´ÜÀÛ¿ë.
  • germicidal action
    »ì±ÕÀÛ¿ë(߯жíÂéÄ).
  • gestagenic action
    ÇÁ·ÎÁ¦½ºÅ×·ÐÀÛ¿ë(¡­íÂéÄ).
  • immediate action
    Áï°¢ÀÛ¿ë, Áï½ÃÀÛ¿ë.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anabolic action
    (´Ü¹é)µ¿È­ÀÛ¿ë(Ó±ÛÜÔÒûùíÂéÄ)
  • analgesic action
    ÁøÅëÀÛ¿ë(òå÷ÔíÂéÄ).
  • anesthetic action
    ¸¶ÃëÀÛ¿ë(¡­íÂéÄ).
  • antidiuretic action
    Ç×ÀÌ´¢ÀÛ¿ë.
  • antifungal action
    Ç×Áø±ÕÀÛ¿ë
  • antimicrobial action
    Ç×±ÕÀÛ¿ë(¡­íÂéÄ).
  • antimuscarinic action
    Ç×¹«½ºÄ«¸°(¼º) ÀÛ¿ë(ù÷¡­(àõ) íÂéÄ).
  • antimuscarinic action
    Ç×¹«½ºÄ«¸°ÀÛ¿ë(ù÷¡­íÂéÄ).
  • antipyretic action
    ÇØ¿­ÀÛ¿ë(¡­íÂéÄ).
  • antispasmodic action
    Áø°æÀÛ¿ë(¡­íÂéÄ)
  • bacteri(o)cidal action
    »ì±ÕÀÛ¿ë(¡­íÂéÄ).
  • bactericidal action
    »ì±ÕÀÛ¿ë
  • bacteriostatic action
    Á¤±ÕÀÛ¿ë(¡­íÂéÄ).
  • ball valve action
    ±¸»ó¹ëºêÀÛ¿ë.
  • ball valve action
    ±¸»ó¹ëºê ÀÛ¿ë(ϹßÑ-íÂéÄ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Primary ovarian follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­Æ÷
  • Primary cephalic vein
    ÀÏÂ÷¸Ó¸®Á¤¸Æ
    [¿¾ ¿ë¾î] ÀÏÂ÷µÎÁ¤¸Æ
  • Primary capillary network
    ÀÏÂ÷¸ð¼¼Ç÷°ü±×¹°
    [¿¾ ¿ë¾î] ÀÏÂ÷¸ð¼¼Ç÷°ü¸Á
  • Primary abdominal implantation
    ÀÏÂ÷¹è¾ÈÂø»ó
    [¿¾ ¿ë¾î] ÀÏÂ÷Àûº¹ºÎÂø»ó
  • Primary bone
    ÀÏÂ÷»À
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ
  • Primary osteon
    ÀÏÂ÷»À´ÜÀ§
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¿ø
  • Primary bone development
    ÀÏÂ÷»À¹ß»ý
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý
  • Primary osteogenic bud
    ÀÏÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý·Ú
  • Primary osteogenic bud
    ÀÏÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÇü¼º¾Æ
  • Primary ossification center
    ÀÏÂ÷»À¹ß»ýÁß½É
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÈ­Áß½É
  • Primary ossification center [Diaphyseal ossification center]
    ÀÏÂ÷»À¹ß»ýÁ᫐ [»À¸öÅë¹ß»ýÁß½É]
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÈ­Áß½É
  • Primary bone trabecula
    ÀÏÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ÒÁÖ
  • Primary trilaminar cortex
    ÀÏÂ÷»ïÃþÆÇ°ÑÁú
    [¿¾ ¿ë¾î] ÀÏÂ÷»ïÃþÆÇÇÇÁú
  • Primary nodule
    ÀÏÂ÷¼ÒÀý
    [¿¾ ¿ë¾î] ÀÏÂ÷¼ÒÀý
  • Primary bud
    ÀÏÂ÷½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷·Ú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary alkali excess
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®°úÀ×(Φí¥)
  • primary alkalosis
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®Áõ(ñø)
  • primary amino acid
    ÀÏÂ÷(ìéó­) ¾Æ¹Ì³ë»ê(ß«)
  • primary bile acid
    ÀÏÂ÷ ´ãÁó»ê(ìéó­ÓÅñðß«)
  • primary carbon dioxide deficit
    ¿ø¹ß¼º ÀÌ»êȭź¼Ò °áÇÌ(ê«Û¡àõì£ß«ûù÷©áÈÌÀù¹)
  • primary carbon dioxide excess
    ¿ø¹ß¼º ÀÌ»êȭź¼Ò(ê´Û¡àõ ì£ß«ûù÷©áÈ) °úÀ×(Φí¥)
  • primary charge effect
    ÀÏÂ÷ ÀüÇÏÈ¿°ú(ìéó­ï³ùÃüùÍý)
  • primary culture
    ÀÏÂ÷ ¹è¾ç(ìéó­ÛÆå×)
  • primary deficiency
    ¿ø¹ß¼º °áÇÌ(ê«Û¡àõÌÀù¹)
  • primary derived protein
    ÀÏÂ÷ À¯µµ ´Ü¹éÁú(ìéó­ë¯ÓôÓ±ÛÜòõ)
  • primary filament
    ÀÏÂ÷(ìéó­) Çʶó¸àÆ®
  • primary fluor
    ÀÏÂ÷ Çü±¤Ã¼(ìéó­û«ÎÃô÷)
  • primary immune response
    ÀÏÂ÷ ¸é¿ª´ëÀÀ(ìéó­Øóæ¹Óßëë)
  • primary ionization
    ÀÏÂ÷(ìéó­) ÀÌ¿ÂÈ­(ûù)
  • primary isotope effect
    ÀÏÂ÷ µ¿À§¿ø¼Ò È¿°ú(ìéó­ÔÒêÈêªáÈüùÍý)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary ray
    ÀÏÂ÷¼±
  • primary tuberculosis
    ÀÏÂ÷°áÇÙ(Áõ), Ãʱâ°áÇÙ(Áõ)
  • primary tumor
    ¿ù¹ßÁ¾¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FAP familial adenomatous polyposis; familial amyloid polyneuropathy; fatty acid polyunsaturated; fatty a...
VAT variable antigen type; ventricular accommodation test; ventricular activation time; vesicular amine ...
PCCM pediatric critical care medicine; primary care case management; primary care case manager
PCP parachlorophenate; patient care plan; pentachlorophenol; 1-(1-phenylcyclohexyl)piperidine; periphera...
PH parathyroid hormone; partial hepatectomy; partial hysterectomy; passive hemagglutination; past histo...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
APD90 Action potential duration
APD(50) Action potential duration at 50
APD(90) Action potential duration at 50% and 90
APD90 action potential durations at 90% repolarization
CAP cochlea action potentials
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • biological action
    »ý¹° ÀÛ¿ë
  • buffer action
    ¿ÏÃæ ÀÛ¿ë
  • calorigenic action
    ¿­ »ý»ê ÀÛ¿ë
    À½½Ä¹° ¶Ç´Â À½½Ä¹° ¼ººÐ¿¡ ÀÇÇØ ü³»¿¡ ¹ß»ýÇÑ ÃÑ ¿¡³ÊÁö·®.
  • cause of action
    ¼Ò¼ÛÀÇ ¿øÀÎ
    ´ëºÎºÐ, ¹ýÀû Á¶Ä¡ÀÇ ¹è°æÀ̳ª ÀÌÀ¯¸¦ ÀǹÌÇÑ´Ù. ¹ýÀû ¹è»óÀ» ÇÏ¿©¾ß ÇÏ´Â À߸øµÈ ¿øÀÎ.
  • central action
    ÁßÃß ÀÛ¿ë
  • chronotropic action
    º¯µ¿ ÀÛ¿ë, º¯½Ã ÀÛ¿ë
  • ciliary action
    ¼¶¸ð ÀÛ¿ë
  • cleaning action
    ¼¼Á¤ ÀÛ¿ë
  • compound action potential
    º¹ÇÕ È°µ¿ Àü¾Ð
  • diabetogenic action
    ´ç´¢º´ À¯¹ß ÀÛ¿ë
  • doping : the action of administering a drug to someone before a sports event
    originally to a horse before a race
    ; the substance thus administered.
  • duration of action
    ÀÛ¿ë Áö¼Ó ½Ã°£
  • dynamic action
    µ¿·Â ÀÛ¿ë
  • electrolytic action
    ÀüÇØ ÀÛ¿ë
  • fungicidal action
    »ìÁø±Õ ÀÛ¿ë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
specific action The action of a drug or a method of treatment which has a direct and especially curative effect upon a disease, e.g., the action of vitamin B12 in pernicious anaemia.
(05 Mar 2000)
specific dynamic action The increase of heat production caused by the ingestion of food, especially of protein.
(05 Mar 2000)
delayed-action preparations Dosage forms of a drug that act over a period of time.
(12 Dec 1998)
thermogenic action Increase of heat production of the body, as by the thyroid hormone.
Synonym: thermogenic action.
(05 Mar 2000)
law of mass action <chemistry> This law states that the rate of a given chemical reaction is proportional to concentration of the reactants.
(09 Oct 1997)
acute primary haemorrhagic meningoencephalitis A disease characterised by acute onset of fever, followed by convulsions, delirium, and coma, and associated with perivascular demyelination and haemorrhagic foci in the central nervous system.
Synonym: acute primary haemorrhagic meningoencephalitis, Strumpell's disease.
(05 Mar 2000)
acyclic monoterpene primary alcohol - NADP oxidoreductase <enzyme> From catmint nepeta racemosa; involved in the biosynthesis of iridoid monoterpenes; oxidises geraniol, nerol, and their 10-hydroxy derivatives in the presence of nadp(+).
Registry number: EC 1.1.1.-
Synonym: monoterpene primary alcohol - nadp oxidoreductase, ampano
(26 Jun 1999)
anterior primary division <anatomy, nerve> The larger, anterolaterally-directed major terminal branch (with the dorsal primary ramus) of all 31 pairs of mixed spinal nerves, formed at the intervertebral foramen. Most ventral primary rami, especially those involved in the innervation of the limbs, participate in the formation of the major nerve plexuses (cervical, brachial, and lumbosacral) and lose their identities. Most in the thoracic region, however, remain separate from adjacent rami to become the intercostal and subcostal nerves. Ventral primary rami provide innervation to the anterolateral body wall and trunk. Nomina Anatomica lists ventral primary rami as "rami ventrales" for each group of spinal nerves: 1) cervical (nervorum cervicalium ), 2) thoracic (nervorum thoracicorum ), 3) lumbar (nervorum lumbalium ), 4) sacral (nervorum sacralium )m, and 5) coccygeal (nervi coccygei ).
Synonym: ramus ventralis nervi spinalis, anterior primary division.
(05 Mar 2000)
aphasia, primary progressive A type of aphasia appearing gradually and gradually worsening without any major change in other cognitive functions. It is regarded by some authors as a syndrome which may be due to various degenerative diseases of the cerebral cortex (notably alzheimer disease, owing to its frequency), while others see in it an autonomous disease related to a neuropathological process that is distinct from the main degenerative dementias. The principal clinical peculiarity of primary progressive aphasia is that it spares the patient's autonomy for a long time, but ultimately turns into global dementia.
(12 Dec 1998)
ventral primary rami of cervical spinal nerves See: ventral primary ramus of spinal nerve.
Synonym: rami ventrales nervorum cervicalium.
(05 Mar 2000)
ventral primary rami of lumbar spinal nerves See: ventral primary ramus of spinal nerve.
Synonym: rami ventrales nervorum lumbalium.
(05 Mar 2000)
ventral primary rami of sacral spinal nerves See: ventral primary ramus of spinal nerve.
Synonym: rami ventrales nervorum sacralium.
(05 Mar 2000)
ventral primary ramus of spinal nerve <anatomy, nerve> The larger, anterolaterally-directed major terminal branch (with the dorsal primary ramus) of all 31 pairs of mixed spinal nerves, formed at the intervertebral foramen. Most ventral primary rami, especially those involved in the innervation of the limbs, participate in the formation of the major nerve plexuses (cervical, brachial, and lumbosacral) and lose their identities. Most in the thoracic region, however, remain separate from adjacent rami to become the intercostal and subcostal nerves. Ventral primary rami provide innervation to the anterolateral body wall and trunk. Nomina Anatomica lists ventral primary rami as "rami ventrales" for each group of spinal nerves: 1) cervical (nervorum cervicalium ), 2) thoracic (nervorum thoracicorum ), 3) lumbar (nervorum lumbalium ), 4) sacral (nervorum sacralium )m, and 5) coccygeal (nervi coccygei ).
Synonym: ramus ventralis nervi spinalis, anterior primary division.
(05 Mar 2000)
Ghon's primary lesion Calcification seen in pulmonary parenchyma (usually mid-lung area) and hilar nodes resulting from earlier, usually childhood, infection with tuberculosis.
Synonym: Ghon's complex, Ghon's focus, Ghon's primary lesion.
(05 Mar 2000)
persistent anterior hyperplastic primary vitreous A unilateral congenital abnormality occurring in full-term infants; characterised by a retrolental fibrovascular membrane formed by persistent primary vitreous with remnants of the hyaloid artery and tunica vasculosa lentis; associated with leukokoria, microphthalmos, shallow anterior chamber, and elongated ciliary processes.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • personal action
    ´ëÀÎ ¼Ò¼Û
  • police action
    ±º´ëÀÇ Ä¡¾È Ȱµ¿;±¹Á¦ ÆòÈ­;Áú¼­ À¯Áö¸¦ À§ÇÑ Á¤±Ô±ºÀÇ Áö¿ªÀûÀÎ ±º»ç Çൿ
  • political action
    Á¤Ä¡Àû ÇàÀ§
  • protective action guide
    ¹æÈ£Ã³Ä¡ ±âÁØ(¹æ»ç¼± Çã¿ë Èí¼ö¼±·®)
  • real action
    ´ë¹° ¼Ò¼Û(¹°°Ç ÀÚüÀÇ È¸º¹À» û±¸ÇÏ´Â)
  • rear-guard action
    Áö¿¬ ÀÛÀü;¼ÓÀÌ´Â(µûµ¹¸®´Â)Çൿ(Àü¼ú) V
  • reflex action
    ¹Ý»ç ÀÛ¿ë
  • shock action
    Ãæ°Ý
  • primary
    Áß¿äÇÑ
  • closed primary
    Á¦ÇÑ ¿¹ºñ ¼±°Å(´ç¿ø À¯ÀÚ°ÝÀÚ¸¸ÀÌ ÅõÇ¥ÇÏ´Â Èĺ¸ÀÚ ¼±°Å)
  • dircct primary
    Á÷Á¢ ¿¹¼±
  • indirect primary
    (¹Ì)°£Á¢ ¿¹ºñ ¼±°Å
  • open primary
    °ø°³ ¿¹¼± ´ëȸ
  • presidential primary
    (°¢ Á¤´çÀÇ)´ëÅë·É ¼±°ÅÀÎ ¿¹¼±È¸
  • primary
    ÃÖÃÊÀÇ;¿ø½ÃÀûÀÎ;¼öÀ§ÀÇ;ÁÖ¿äÇÑ;º»·¡ÀÇ;±Ùº»ÀÇ;Ãʺ¸ÀÇ;Á¦ 1±âÀÇ;1Â÷ÀÇ-Á¦ 1À§ÀÇ »ç¹°;¿ø»ö;ÀÏÂ÷¾î(¸í»ç »ó´ç ¾î±¸);´ëÅë·É Èĺ¸ ¿¹ºñ ¼±°Å
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á